WELL Health
Trending >

Why is CBD all the rage?

Charlotte’s Web Holdings

CBD all the rageWhy is CBD All the Rage?

It’s only been in the last few months that consumers have been introduced to CBD and its potential benefits; we’re at the beginning, the industry has just leapt out of the starting blocks. While CBD has been dominating recent headlines, many consumers and investors are left asking ‘what exactly is CBD’ and perhaps, most importantly, ‘why is everyone talking about it’?

At the end of 2018, the Agriculture Improvement Act of 2018 (the “Act”) or Farm Bill 2018, as it is commonly known, was signed by President Donald Trump. The Act encompasses a wide variety of programs, ranging from food stamps and crop insurance programs, to subsidies for starting new farms and ranches, but what stood out for many was the legalization of industrial hemp.

Where does CBD fit into the Farm Bill?

The passage of the Act meant that hemp-derived products were no longer considered a Schedule I product under the Control and Substance Act. As a result, hemp-derived cannabidiol (also known as, CBD) is now legal.

Without getting into the science of CBD (if you are interested, you can learn more here), it’s worth mentioning that CBD differs from marijuana because it contains no more than 0.3% (by dry weight) THC (THC is the psychoactive element of cannabis). While there is still vast amounts of medical research to be done on CBD, there is some evidence that it can help with children’s seizures and can also help manage anxiety and insomnia.

What does this mean for the CBD industry?

 

A recent study by Cowen & Co. found that up to 7% of Americans are using CBD. It also found that in 2018, sales were estimated to be between $600M-$2B, but with the recent increase in awareness and regulatory changes, estimates show that the market could grow to $16B in sales by 2025.

You might be thinking, how is that possible? Well, it only took a few months before we began to see how this astronomical growth could actually happen; CVS and Walgreens have already begun to sell CBD across the U.S, and many apparel and accessories retailers, such as Designer Brands and Urban Outfitters, have also begun selling CBD products. In short, legalization opens many large distribution channels.

Earlier this year TSX celebrated the listing of Charlotte’s Web Holdings, a pioneer in the CBD industry. This marked another milestone for the Stanley Brothers, who were joined by their mother in Boulder, Colorado, to celebrate the company they founded that became famous for developing a product that would alleviate the suffering of Charlotte Figi, who suffered from a severe form of epilepsy called Dravet’s Syndrome. Overlooking the Boulder Flatirons, TSX celebrated this historic listing with the company founders and management team.

Deanie Eiser, recently appointed as CEO of the company, reiterated her comments from the Q1 analyst call at the market open, stating that a TSX listing will provide: “a larger reach to international institutional investors, enhanced liquidity, specialized indices, greater visibility and opportunities for greater coverage internationally.”

And while I usually see fist pumping and hooting and hollering at market opens, this one truly had an uplifting, family feel, as the brothers hugged each other throughout the ceremony, and all made sure to hug their mother.

 

This article is provided for information purposes only, is not intended to provide any type of advice. This article is not an endorsement or recommendation of any securities or industry referenced herein. Views, comments or opinions expressed in this article are those of their respective contributors only, and are not necessarily endorsed by TMX Group Limited, any of its affiliates or their respective management or employees.

 

More from Cantech Letter

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

About The Author /

DANI LIPKIN Director, Global Business Development, Toronto Stock Exchange and TSX Venture Exchange Dani Lipkin is Director of Global Business Development for Toronto Stock Exchange and TSX Venture Exchange. Prior to this role, Dani was Innovation Sector Head for Toronto Stock Exchange and TSX Venture Exchange and before that Dani was the Head of Business Development for Exchange Traded Funds (ETFs) and Investment Funds on TSX. He had also worked with the listings group for TSX, where he helped assist companies in going public. Dani holds a Bachelor of Management and Organizational Studies in Finance from the University of Western Ontario and an MBA from the University of Toronto.
insta twitter facebook

Comment

Leave a Reply

RELATED POSTS